Interview with Dr. Thomas Costa of Coventya

ndetails

In the new episode of the alpha Talks Podcast, Enno Krey speaks to Dr. Thomas Costa, former CEO of Coventya (acquired by MacDermid Enthone in 2021), a leading international specialty chemicals company. Thomas has successfully led Coventya through 20 years of PE ownership before it was acquired by Element Solutions Inc (NYSE:ESI) this year.

Thomas speaks about his journey and the lessons learnt as a successful Private Equity CEO.

Listen to the podcast:

You can subscribe to the podcast on your favourite podcast platform:

Spotify

Apple Podcasts

alpha Talks is the podcast dedicated to Private Equity value growth. Enno speaks to experienced buyout CEOs, operating partners, deal makers and advisors about their experience and lessons-learned in the industry.

Related Insights

Reorganization – Liberate or Incapacitate: The Choice is Yours
17 Dec, 2024 By Humatica

Reorganization – Liberate or Incapacitate: The Choice is Yours

CEOs envisioning a new organizational structure often face a daunting question: how do I bring this vision to life across my organization? The stakes are…

Read more arrowicon
Increasing Organizational Effectiveness with Humatica’s AI-enabled toolkit
27 Nov, 2024 By Humatica

Increasing Organizational Effectiveness with Humatica’s AI-enabled toolkit

Private Equity thrives on unlocking value in portfolio companies through governance improvements and strategic interventions. Yet, as economic and market complexities increase, the challenge of…

Read more arrowicon
Mastering the new science of engineered management decision processes
28 Oct, 2024 By Humatica

Mastering the new science of engineered management decision processes

Despite huge efforts to improve operational processes over the past 20 years, critically important management processes are left up to the discretion of each manager…

Read more arrowicon

Subscribe to our Monthly Newsletter and other News Updates

Receive our news and valuable perspectives on organizational effectiveness each month.